Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formylated N-heterocyclic derivatives as FGFR4 inhibitors

Formylated N-heterocyclic derivatives as FGFR4 inhibitors

US Patent 10786492 · Granted Sep 29, 2020

Estimated economic value: $23,191,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Pyrazolyl derivatives useful as anti-cancer agents2023
Pyrazolyl derivatives useful as anti-cancer agents2023
Combinations of FGFR4 inhibitors and bile acid sequestrants2022
Compounds and compositions as inhibitors of endosomal toll-like receptors2021
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019